The serotonergic system in ageing and Alzheimer's disease

被引:212
作者
Julio Rodriguez, Jose [1 ,2 ,3 ,4 ]
Noristani, Harun N. [5 ]
Verkhratsky, Alexei [1 ,2 ,3 ,5 ]
机构
[1] Basque Fdn Sci, IKERBASQUE, Bilbao 48011, Spain
[2] Hosp Donostia, Inst Invest Sanitaria Biodonostia, San Sebastian 20014, Spain
[3] Ctr Invest Biomed Red Enfermedades Neurodegenerat, San Sebastian 20014, Spain
[4] ASCR, Inst Expt Med, Prague 14220, Czech Republic
[5] Univ Manchester, Fac Life Sci, Manchester, Lancs, England
基金
英国生物技术与生命科学研究理事会;
关键词
Alzheimer's disease; Dementia; Serotonin; Serotonin transporter; Serotonin receptors; Hippocampus; Raphe nucleus; Plasticity; ACUTE TRYPTOPHAN DEPLETION; AGE-RELATED-CHANGES; 5-HT1A RECEPTOR-BINDING; TRANSGENIC MOUSE MODEL; CENTRAL-NERVOUS-SYSTEM; NUCLEUS RAPHE DORSALIS; LATE-LIFE DEPRESSION; SERUM VASOCONSTRICTOR SEROTONIN; MILD COGNITIVE IMPAIRMENT; MESSENGER-RNA EXPRESSION;
D O I
10.1016/j.pneurobio.2012.06.010
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Alzheimer's disease (AD) is one of the major neurodegenerative diseases that deteriorates cognitive functions and primarily affects associated brain regions involved in learning and memory, such as the neocortex and the hippocampus. Following the discovery and establishment of its role as a neurotransmitter, serotonin (5-HT), was found to be involved in a multitude of neurophysiological processes including mnesic function, through its dedicated pathways and interaction with cholinergic, glutamatergic, GABAergic and dopaminergic transmission systems. Abnormal 5-HT neurotransmission contributes to the deterioration of cognitive processes in ageing, AD and other neuropathologies, including schizophrenia, stress, mood disorders and depression. Numerous studies have confirmed the pathophysiological role of the 5-HT system in AD and that several drugs enhancing 5-HT neurotransmission are effective in treating the AD-related cognitive and behavioural deficits. Here we present a comprehensive overview of the role of serotonergic neurotransmission in brain development, maturation and ageing, discuss its role in higher brain function and provide an in depth account of pathological modifications of serotonergic transmission in neurological diseases and AD. (C) 2012 Elsevier Ltd. All rights reserved.
引用
收藏
页码:15 / 41
页数:27
相关论文
共 494 条
[1]   Pharmacological characterization of RS-1259, an orally active dual inhibitor of acetylcholinesterase and serotonin transporter, in rodents: Possible treatment of Alzheimer's disease [J].
Abe, Y ;
Aoyagi, A ;
Hara, T ;
Abe, K ;
Yamazaki, R ;
Kumagae, Y ;
Naruto, S ;
Koyama, K ;
Marumoto, S ;
Tago, K ;
Toda, N ;
Takami, K ;
Yamada, N ;
Ori, M ;
Kogen, H ;
Kaneko, T .
JOURNAL OF PHARMACOLOGICAL SCIENCES, 2003, 93 (01) :95-105
[2]   5-HT2 receptor regulation of extracellular GABA levels in the prefrontal cortex [J].
Abi-Saab, WM ;
Bubser, M ;
Roth, RH ;
Deutch, AY .
NEUROPSYCHOPHARMACOLOGY, 1999, 20 (01) :92-96
[3]   Antidepressants are a rational complementary therapy for the treatment of Alzheimer's disease [J].
Aboukhatwa, Marwa ;
Dosanjh, Laura ;
Luo, Yuan .
MOLECULAR NEURODEGENERATION, 2010, 5
[4]   Serotonin, via 5-HT2A receptors, increases EPSCs in layer V pyramidal cells of prefrontal cortex by an asynchronous mode of glutamate release [J].
Aghajanian, GK ;
Marek, GJ .
BRAIN RESEARCH, 1999, 825 (1-2) :161-171
[5]   CELL LOSS IN THE NUCLEUS-RAPHES-DORSALIS IN ALZHEIMERS-DISEASE [J].
ALETRINO, MA ;
VOGELS, OJM ;
VANDOMBURG, PHMF ;
TENDONKELAAR, HJ .
NEUROBIOLOGY OF AGING, 1992, 13 (04) :461-468
[6]   THE QUIPAZINE-INCREASED AND TFMPP-INCREASED CONDITIONED AVOIDANCE-RESPONSE IN RATS - ROLE OF 5-HT1C/5-HT2 RECEPTORS [J].
ALHAIDER, AA ;
AGEEL, AM ;
GINAWI, OT .
NEUROPHARMACOLOGY, 1993, 32 (12) :1427-1432
[7]   Serotonin mediates CA1 spine density but is not crucial for ovarian steroid regulation of synaptic plasticity in the adult rat dorsal hippocampus [J].
Alves, SE ;
Hoskin, E ;
Lee, SJ ;
Brake, WG ;
Ferguson, D ;
Luine, V ;
Allen, PB ;
Greengard, P ;
McEwen, BS .
SYNAPSE, 2002, 45 (02) :143-151
[8]  
Alzheimer A., 1907, Allg Zeitschrift Psychiatr, V64, P146, DOI DOI 10.1002/CA.980080612
[9]   AN ANALYSIS OF THE ORIGINS OF THE CHOLINERGIC AND NONCHOLINERGIC SEPTAL PROJECTIONS TO THE HIPPOCAMPAL-FORMATION OF THE RAT [J].
AMARAL, DG ;
KURZ, J .
JOURNAL OF COMPARATIVE NEUROLOGY, 1985, 240 (01) :37-59
[10]   THE DISTRIBUTION OF SUBSTANCE-P AND 5-HYDROXYTRYPTAMINE IN THE CENTRAL NERVOUS SYSTEM OF THE DOG [J].
AMIN, AH ;
CRAWFORD, TBB ;
GADDUM, JH .
JOURNAL OF PHYSIOLOGY-LONDON, 1954, 126 (03) :596-618